Cointime

Promentis Pharmaceuticals

company

About

Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

  • 11 - 50

Highlights

Total Funding Amount
$1.80M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.80M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia.

Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.80M
Promentis Pharmaceuticals has raised a total of $1.80M in funding over 2 rounds. Their latest funding was raised on Sep 25, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 25, 2012 Grant $1.80M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Promentis Pharmaceuticals is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท